Home / Costs / Stem Cell Transplant Cost in Delhi

Stem Cell Transplant Cost in Delhi

category Bone Marrow Transplant heart_check Blood Cancer

Stem cell transplant (hematopoietic cell transplant, or HCT) at Dr. Satyendra Katewa’s practice in Delhi ranges from ₹10,00,000 to ₹35,00,000, depending on transplant type and donor source. Autologous transplants (using the patient’s own stem cells) start at the lower end. Matched unrelated donor and haploidentical transplants cost more due to donor search, matching, and procurement.

A written cost estimate is provided after clinical evaluation. International patients can request an estimate in USD, GBP, or AED.

Reach Out for Expert Care

Introduction

A peer-reviewed analysis of the hematopoietic cell transplant landscape in India found that nearly 60-70% of patients needing an allogeneic transplant will not find a matched sibling donor. This single statistic shapes everything: the clinical strategy, the timeline, and the cost.

For families managing a leukaemia, thalassaemia,aplastic anaemia, or lymphoma diagnosis in a child or young adult, knowing how transplant costs are structured is not a financial exercise; it is a necessary planning.

Dr. Satyendra Katewa, Director of the Paediatric Haemato-Oncology and BMT programme at Max Super Speciality Hospital, Patparganj, Delhi, has guided over 1,000 families through precisely this planning process over 25+ years of clinical practice.

This page provides the factual, transparent cost framework his team uses to prepare families for the first consultation.

How Much Does a Stem Cell Transplant Cost in Delhi?

At Dr. Katewa’s practice in Delhi, stem cell transplant costs range from ₹10,00,000 to ₹35,00,000.

Autologous transplants, where the patient’s own stem cells are used, sit at the lower end. Allogeneic transplants using a matched sibling donor cost more.

Transplants requiring a matched unrelated donor (MUD) or haploidentical (half-matched) donor cost the most, because donor identification, HLA typing, and procurement add significantly to the overall total.

The single biggest variable driving cost up or down is donor source. After that, disease type, conditioning intensity, and the complexity of post-transplant management play the largest roles.

Average treatment cost at Dr. Katewa’s practice:

Transplant Type  Indicative Cost Range (₹)
Autologous HCT (patient’s own stem cells) ₹10,00,000 – ₹15,00,000
Matched Sibling Donor (MSD) allogeneic HCT ₹12,00,000 – ₹20,00,000
Haploidentical (half-matched family donor) HCT ₹18,00,000 – ₹28,00,000
Matched Unrelated Donor (MUD) HCT ₹22,00,000 – ₹35,00,000
Cord Blood HCT ₹20,00,000 – ₹32,00,000

 

These are base treatment cost ranges. A written personalised estimate is provided after full clinical evaluation, HLA typing results, and disease assessment as required by the ICMR 2021 National Guidelines for Hematopoietic Cell Transplantation.

If your assessment indicates that additional clinical steps are needed, your specialist will discuss these with you and provide a written breakdown before anything is added to your plan.

What Does a Stem Cell Transplant Cycle Include?

A standard stem cell transplant cycle covers every clinical stage from initial work-up to long monitoring. Here is what the base treatment cost encompasses at Dr. Katewa’s programme:

  • Pre -Transplant Evaluation

A thorough assessment of the patient’s disease status, organ function, and infectious disease status. This includes full blood counts, metabolic panels, viral screening (HIV, hepatitis, CMV), bone marrow biopsy, imaging (PET-CT or CT scan), cardiac echo, and pulmonary function tests.

  • Donor Identification and Workup

For allogeneic transplants, this covers sibling HLA typing, donor medical evaluation, and, where needed, domestic registry search fees and donor stem cell collection (apheresis or bone marrow harvest).

  • Conditioning Therapy

High-dose chemotherapy, and in some cases total body irradiation (TBI), given in the days before transplant. The intensity of the conditioning regimen (myeloablative versus reduced-intensity) is chosen based on the patient’s age, disease, and organ reserves.

  • Stem Cell Infusion

The transplant itself infusion of healthy stem cells through a central venous catheter. For most patients, this takes a few hours and resembles a blood transfusion.

  • Inpatient Stay in a HEPA-Filtered BMT Unit

All patients are nursed in HEPA-filtered, positive-pressure isolation rooms throughout the engraftment phase. The BMT unit at Max Super Speciality Hospital, Patparganj, meets the infrastructure requirements set out in the ICMR 2021 national guidelines.

  • Engraftment Monitoring

Daily blood counts, infection surveillance, and graft-versus-host disease (GVHD) monitoring. Engraftment, when the new stem cells begin producing healthy blood cells, typically occurs within 14-21 days of transplant.

  • Post-Discharge Outpatient Follow-Up (100 Days)

The first 100 days after transplant carry the highest risk of serious complications. Structured outpatient follow-up visits, blood tests, and medication adjustments are included in the standard treatment cost through this period.

If your clinical assessment indicates any additional procedures, your specialist will discuss these with you and provide a written cost breakdown before anything is added to your plan.

What Factors Affect the Cost of a Stem Cell Transplant?

Donor source is the most powerful cost driver; moving from a matched sibling to an unrelated donor can more than double procurement costs alone.

  • Patient Age and Overall Health

Younger patients with good organ function can usually tolerate myeloablative (full-intensity) conditioning, which tends to have a more predictable cost profile.

Older patients, or those with organ compromise from prior chemotherapy, may need reduced-intensity conditioning with additional supportive care, which affects the length and complexity of the inpatient stay.

  • Conditioning Protocol and Intensity

Myeloablative conditioning, the standard approach for most paediatric transplants, requires more intensive supportive care, more days of inpatient stay, and more transfusion support than reduced-intensity protocols.

The choice is clinical, not financial, but it affects the overall cost.

  • Underlying Diagnosis

The disease being treated determines how the transplant is designed. Thalassaemia, aplastic anaemia, and primary immunodeficiencies follow different conditioning protocols from those for leukaemias and lymphomas.

You can read more about the conditions managed under Dr. Katewa’s blood cancer programme.

  • Number of Treatment Courses Required

Most patients receive a single transplant course. However, primary graft failure, where the new stem cells do not engraft successfully, requires a second transplant.

This is uncommon but adds substantially to the total cost. The risk is higher with unrelated and cord blood donors.

  • Additional Procedures

Some patients need procedures beyond the base transplant: donor lymphocyte infusion (DLI) for relapse prevention or treatment, or in some cases CAR T cell therapy for relapsed or refractory disease.

When clinically indicated, each is priced separately and confirmed in writing before it is added to the treatment plan.

  • Donor Source

This is the single largest cost variable. A matched sibling donor (a healthy brother or sister with a full HLA match) costs far less than an unrelated donor found through a national or international registry. Domestic registry searches cost more than sibling typing.

International unrelated donor procurement sourced through registries outside India involves registry fees, donor activation costs, and international logistics, which can add to the total.

  • Stem Cell and Sample Storage

If stem cells are collected and cryopreserved before conditioning therapy, common in autologous transplants, storage fees apply.

In some allogeneic cases, the donor’s back-up stem cell collection may be stored in case of engraftment failure. Storage duration and facility standards affect the cost.

  • Clinical Infrastructure and Specialist Experience

HEPA-filtered BMT units, dedicated BMT nursing staff trained in isolation care, 24-hour infection control, and access to blood bank services all affect the daily cost of inpatient care.

The experience of the transplant physician shapes the protocols used for GVHD prevention and infection management, which in turn affects the length of hospital stay.

Stem Cell Transplant Cost Breakdown by Type

The table below shows current indicative market ranges for Delhi across transplant types. These are Delhi market data points drawn from published treatment pricing surveys for Delhi and clinical cost data. They are not fixed prices. A personalised written estimate is confirmed at the consultation.

Transplant Type Approximate Range in Delhi
Autologous HCT ₹10,00,000- ₹15,00,000
Matched Sibling Donor (MSD) Allogeneic HCT ₹12,00,000 – ₹20,00,000
Haploidentical (Half-Matched) HCT ₹18,00,000 – ₹28,00,000
Matched Unrelated Donor (MUD) HCT Domestic Registry ₹22,00,000 – ₹30,00,000
Matched Unrelated Donor (MUD) HCT  International Registry ₹28,00,000 – ₹35,00,000+
Cord Blood HCT ₹20,00,000 – ₹32,00,000

These are indicative costs only. They do not represent fixed prices at any single hospital. A personalised written estimate based on your clinical assessment is confirmed before treatment begins.

Stem Cell Transplant Success Rate by Age

Age at transplant is one of the strongest predictors of outcome. Children and adolescents achieve the highest survival rates from stem cell transplants. Outcomes in young adults remain strong when the disease is caught early. Adults over 40 can achieve durable remissions, but the risk-benefit calculation is more individualised. Here is the evidence by age group.

Age Group Typical Transplant Approach Key Outcome Driver
Children < 18 Myeloablative conditioning (MAC) Disease type and stage at transplant
Young adults 18-40Y MAC or RIC, depending on disease and organ function Donor match quality and remission status
Adults 40-60 RIC preferred disease biology
Adults > 60 Selected cases only; RIC Performance status and organ function

Stem Cell Transplant Process at Dr. Satyendra Katewa, Delhi

Understanding each clinical stage helps families know what they are paying for at every step.

Step 1: Initial Consultation and Disease Staging

  • Dr. Katewa reviews the complete medical history, pathology reports, and imaging.
  • For patients referred from outside Delhi, remote consultations are available before travel.

Step 2: Pre-Transplant Evaluation and HLA Typing

  • A structured work-up assesses every organ system that conditioning will stress.
  • Blood tests, bone marrow biopsy, imaging, cardiac echo, and pulmonary function tests are performed.

Step 3: Donor Identification and Workup

  • If no matched sibling is available, the transplant team initiates a search through a domestic or international donor registry.
  • Potential donors undergo a full medical evaluation to confirm fitness for stem cell donation.

Step 4: Conditioning Therapy

  • Conditioning, the preparative step, is performed over the 5-10 days before the transplant.
  • It destroys residual disease and suppresses the immune system enough to accept the incoming donor cells.
  • Conditioning may involve high-dose chemotherapy alone or a combination of chemotherapy and total body irradiation (TBI), depending on the diagnosis.

Step 5: Stem Cell Infusion (Transplant Day)

The stem cells, whether collected from the patient (autologous) or from a donor (allogeneic), are infused through a central venous catheter. The infusion itself takes a few hours. The patient is monitored closely for immediate reactions throughout.

Step 6: Engraftment Phase

  • The patient remains in a HEPA-filtered, positive-pressure isolation room while awaiting engraftment of the new stem cells. Daily blood counts track progress.
  • The team closely monitors for infection, organ stress, and, in allogeneic transplants, early signs of graft-versus-host disease (GVHD), a condition in which donor immune cells attack the patient’s healthy tissues.

Step 7: Post-Engraftment Recovery 

Once stable blood counts confirm engraftment, the patient is discharged for structured follow-up.

Stem Cell Transplant Cost in Delhi vs Other Major Indian Cities

Delhi offers one of the most competitive cost-to-capability ratios in India for stem cell transplant, particularly for paediatric cases. The table below shows the current indicative private hospital market ranges across six Indian cities, by transplant type.

City Autologous HCT Matched Sibling (MSD) Haploidentical
Delhi / NCR ₹10L – ₹15L ₹12L – ₹20L ₹18L – ₹35L
Mumbai ₹10L – ₹22L ₹18L – ₹30L ₹22L – ₹38L
Bangalore ₹11L – ₹18L ₹14L – ₹24L ₹18L – ₹32L
Chennai ₹10L – ₹17L ₹13L – ₹22L ₹16L – ₹30L
Hyderabad ₹9L – ₹16L ₹12L – ₹22L ₹16L – ₹30L
Kolkata ₹9L – ₹15L ₹11L – ₹20L ₹15L – ₹28L

Indicative private hospital market ranges only, sourced from published Delhi market pricing surveys and city-level clinical cost data. A personalised written estimate is confirmed after clinical evaluation.

Book a consultation to receive a written estimate specific to your case.

Why Choose Dr. Satyendra Katewa for Stem Cell Transplant in Delhi?

Dr. Katewa’s programme at Max Super Speciality Hospital, Patparganj, is built specifically around children with complex blood disorders and cancers.

  • 1,000+ Paediatric BMT Cases: High-volume experience in children, unmatched by many regional centres.
  • 25+ Years and Harvard/SickKids Training: Fellowship training at the Hospital for Sick Children (SickKids), Toronto, and Harvard University means the protocols used here meet international standards.
  • International Society Memberships: Active member of ASBMT, SIOP, ASPHO, and ESID, four bodies that set and update global transplant and paediatric oncology standards.
  • All Transplant Types Under One Programme: Autologous, matched sibling, haploidentical, and matched-unrelated donor transplants are all available within the same clinical team.
  • ICMR-Compliant Infrastructure: HLA typing at a NABL-accredited laboratory and a HEPA-filtered BMT unit that meets the minimum standards set by the ICMR 2021 National Guidelines for Hematopoietic Cell Transplantation.
  • International Patient Support: Dedicated patient coordinator, written cost estimates in USD, GBP, or AED, Medical Visa (M Visa) invitation letter support, and remote pre-consultation before travel.

Book a Consultation → | WhatsApp Us →

Stem Cell Transplant in Delhi for International Patients

India offers stem cell transplant at a fraction of the cost compared to the US, UK, or the Middle East.

A transplant that costs USD 200,000-400,000 in the United States can be performed at comparable clinical standards in Delhi for a fraction of that figure.

International patients receive:

  • A written cost estimate in the preferred currency, issued before travel
  • Medical Visa (M Visa) invitation letter support for patients and one accompanying caregiver
  • Remote pre-consultation before arrival, so work-up can be partially completed in the home country
  • A single dedicated international patient coordinator with direct contact details
  • Documentation for home country insurance reimbursement claims, including itemised cost summaries, discharge summaries in English, and treatment outcome reports

For an international patient enquiry, contact the team directly via WhatsApp or use the enquiry form below.

Take The First Step Towards Better Health

Things are worth taking away from this page.

  • First, the donor source is the primary cost driver for stem cell transplant in Delhi: knowing early whether a matched sibling is available shapes both the clinical plan and the financial one.
  • Second, outcomes are best, and costs are most predictable, when patients are referred before complications of the underlying disease accumulate.

Dr. Katewa’s team will confirm your indicative cost in writing after a single clinical evaluation.

Book a consultation today to receive a full clinical assessment and a personalised written cost estimate.

Book Appointment Online →

WhatsApp Us Directly →

Request a Callback | Submit a Cost Enquiry

Dr. Satyendra Katewa's Medical Content Team

Dr. Satyendra Katewa's Medical Content Team

Dr. Satyendra Katewa’s medical content team specialises in developing accurate, evidence-based, and patient-focused healthcare content. With strong clinical insight and expertise in medical writing and SEO, the team simplifies complex haematology and oncology information into clear, trustworthy resources that support informed decision-making and reflect Dr. Katewa’s commitment to ethical, compassionate care.

This content is reviewed by Dr. Satyendra Katewa

Related Articles

5-Year-Old Girl Defeats Thalassemia After Successful Half-Match Bone Marrow Transplant in Delhi

5-Year-Old Girl Defeats Thalassemia After Successful Half-Match Bone Marrow Transplant in Delhi

For most children, early childhood is filled with school, playtime, and birthdays. But for Zehra,…

Read Article →
Best Paediatric Haemato-Oncologists in Delhi

Best Paediatric Haemato-Oncologists in Delhi

When a child is referred to a cancer or blood disorder specialist, it can be…

Read Article →
WhatsApp logo WhatsApp